ID   GLYG_HUMAN              Reviewed;         350 AA.
AC   P46976; D3DNH0; D3DNH1; D3DNH2; Q6FHZ1; Q9UNV0;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=Glycogenin-1;
DE            Short=GN-1;
DE            Short=GN1;
DE            EC=2.4.1.186;
GN   Name=GYG1; Synonyms=GYG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GN-1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=8602861; DOI=10.1006/bbrc.1996.0359;
RA   Barbetti F., Rocchi M., Bossolasco M., Cordera R., Sbraccia P.,
RA   Finelli P., Consalez G.G.;
RT   "The human skeletal muscle glycogenin gene: cDNA, tissue expression
RT   and chromosomal localization.";
RL   Biochem. Biophys. Res. Commun. 220:72-77(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GN-1).
RX   PubMed=8661012; DOI=10.1006/geno.1996.0228;
RA   Lomako J., Mazuruk K., Lomako W.M., Alonso M.D., Whelan W.J.,
RA   Rodriguez I.R.;
RT   "The human intron-containing gene for glycogenin maps to chromosome 3,
RT   band q24.";
RL   Genomics 33:519-522(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORM GN-1S).
RC   TISSUE=Skin;
RA   Leffers H., Wiemann S., Ansorge W.;
RL   Submitted (JUN-1994) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM GN-1).
RX   PubMed=10395894; DOI=10.1016/S0378-1119(99)00211-5;
RA   van Maanen M.-H., Fournier P.A., Palmer T.N., Abraham L.J.;
RT   "Characterization of the human glycogenin-1 gene: identification of a
RT   muscle-specific regulatory domain.";
RL   Gene 234:217-226(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ISOFORM GN-1L), AND ALTERNATIVE SPLICING.
RX   PubMed=10721716; DOI=10.1016/S0378-1119(99)00520-X;
RA   Zhai L., Mu J., Zong H., DePaoli-Roach A.A., Roach P.J.;
RT   "Structure and chromosomal localization of the human glycogenin-2 gene
RT   GYG2.";
RL   Gene 242:229-235(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GN-1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM GN-1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH GYS1.
RX   PubMed=17055998; DOI=10.1016/j.abb.2006.09.024;
RA   Skurat A.V., Dietrich A.D., Roach P.J.;
RT   "Interaction between glycogenin and glycogen synthase.";
RL   Arch. Biochem. Biophys. 456:93-97(2006).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [14]
RP   INVOLVEMENT IN PGBM2, AND VARIANTS PGBM2 PRO-16 AND HIS-102.
RX   PubMed=25272951; DOI=10.1002/ana.24284;
RA   Malfatti E., Nilsson J., Hedberg-Oldfors C., Hernandez-Lain A.,
RA   Michel F., Dominguez-Gonzalez C., Viennet G., Akman H.O., Kornblum C.,
RA   Van den Bergh P., Romero N.B., Engel A.G., DiMauro S., Oldfors A.;
RT   "A new muscle glycogen storage disease associated with glycogenin-1
RT   deficiency.";
RL   Ann. Neurol. 76:891-898(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 1-262.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human glycogenin-1 (GYG1), apo form.";
RL   Submitted (FEB-2011) to the PDB data bank.
RN   [16]
RP   VARIANT GSD15 MET-83, AND CHARACTERIZATION OF VARIANT GSD15 MET-83.
RX   PubMed=20357282; DOI=10.1056/NEJMoa0900661;
RA   Moslemi A.R., Lindberg C., Nilsson J., Tajsharghi H., Andersson B.,
RA   Oldfors A.;
RT   "Glycogenin-1 deficiency and inactivated priming of glycogen
RT   synthesis.";
RL   N. Engl. J. Med. 362:1203-1210(2010).
CC   -!- FUNCTION: Self-glucosylates, via an inter-subunit mechanism, to
CC       form an oligosaccharide primer that serves as substrate for
CC       glycogen synthase.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucose + glycogenin = UDP +
CC       alpha-D-glucosylglycogenin.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Note=Divalent metal ions. Required for self-glucosylation.
CC       Manganese is the most effective.;
CC   -!- PATHWAY: Glycan biosynthesis; glycogen biosynthesis.
CC   -!- SUBUNIT: Homodimer tightly complexed to the 86 kDa catalytic
CC       subunit of glycogen synthase GYS1 (By similarity). Interacts (via
CC       C-terminus) with GYS2 (PubMed:17055998). This interaction is
CC       required for GYS2-mediated glycogen synthesis (By similarity).
CC       {ECO:0000250|UniProtKB:P13280, ECO:0000250|UniProtKB:Q9R062,
CC       ECO:0000269|PubMed:17055998}.
CC   -!- INTERACTION:
CC       P13807:GYS1; NbExp=7; IntAct=EBI-740533, EBI-740553;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=GN-1L;
CC         IsoId=P46976-1; Sequence=Displayed;
CC       Name=GN-1;
CC         IsoId=P46976-2; Sequence=VSP_001769;
CC       Name=GN-1S;
CC         IsoId=P46976-3; Sequence=VSP_001768;
CC   -!- PTM: Self-glycosylated by the transfer of glucose residues from
CC       UDP-glucose to itself, forming an alpha-1,4-glycan of around 10
CC       residues attached to Tyr-195.
CC   -!- PTM: Phosphorylated. {ECO:0000250}.
CC   -!- DISEASE: Glycogen storage disease 15 (GSD15) [MIM:613507]: A
CC       metabolic disorder resulting in muscle weakness, associated with
CC       the glycogen depletion in skeletal muscle, and cardiac arrhythmia,
CC       associated with the accumulation of abnormal storage material in
CC       the heart. The skeletal muscle shows a marked predominance of
CC       slow-twitch, oxidative muscle fibers and mitochondrial
CC       proliferation. {ECO:0000269|PubMed:20357282}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Polyglucosan body myopathy 2 (PGBM2) [MIM:616199]: A
CC       glycogen storage disease characterized by polyglucosan
CC       accumulation in muscle, and skeletal myopathy without cardiac
CC       involvement. Most patients manifest slowly progressive, hip
CC       girdle, shoulder girdle, and/or hand and leg muscle weakness.
CC       Polyglucosan contains abnormally long and poorly branched glucosyl
CC       chains and is variably resistant to digestion by alpha-amylase.
CC       {ECO:0000269|PubMed:25272951}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 8 family.
CC       Glycogenin subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U44131; AAB00114.1; -; mRNA.
DR   EMBL; U31525; AAB09752.1; -; mRNA.
DR   EMBL; X79537; CAA56073.1; -; mRNA.
DR   EMBL; AF065481; AAD31084.1; -; Genomic_DNA.
DR   EMBL; AF065476; AAD31084.1; JOINED; Genomic_DNA.
DR   EMBL; AF065477; AAD31084.1; JOINED; Genomic_DNA.
DR   EMBL; AF065478; AAD31084.1; JOINED; Genomic_DNA.
DR   EMBL; AF065479; AAD31084.1; JOINED; Genomic_DNA.
DR   EMBL; AF065480; AAD31084.1; JOINED; Genomic_DNA.
DR   EMBL; AF087942; AAD52093.1; -; mRNA.
DR   EMBL; CR536547; CAG38784.1; -; mRNA.
DR   EMBL; AC021059; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78894.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78895.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78896.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78898.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78900.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78901.1; -; Genomic_DNA.
DR   EMBL; BC000033; AAH00033.1; -; mRNA.
DR   CCDS; CCDS3139.1; -. [P46976-1]
DR   CCDS; CCDS54654.1; -. [P46976-2]
DR   CCDS; CCDS54655.1; -. [P46976-3]
DR   PIR; JC4695; JC4695.
DR   RefSeq; NP_001171649.1; NM_001184720.1. [P46976-2]
DR   RefSeq; NP_001171650.1; NM_001184721.1. [P46976-3]
DR   RefSeq; NP_004121.2; NM_004130.3. [P46976-1]
DR   UniGene; Hs.477892; -.
DR   PDB; 3Q4S; X-ray; 1.98 A; A=1-262.
DR   PDB; 3QVB; X-ray; 2.26 A; A=1-262.
DR   PDB; 3RMV; X-ray; 1.82 A; A=1-262.
DR   PDB; 3RMW; X-ray; 1.93 A; A=1-262.
DR   PDB; 3T7M; X-ray; 1.80 A; A/B=1-262.
DR   PDB; 3T7N; X-ray; 1.98 A; A/B=1-262.
DR   PDB; 3T7O; X-ray; 1.85 A; A/B=1-262.
DR   PDB; 3U2T; X-ray; 2.05 A; A=1-262.
DR   PDB; 3U2U; X-ray; 1.45 A; A/B=1-262.
DR   PDB; 3U2V; X-ray; 1.50 A; A/B=1-262.
DR   PDB; 3U2W; X-ray; 1.68 A; A/B=1-262.
DR   PDB; 3U2X; X-ray; 1.77 A; A/B=1-262.
DR   PDBsum; 3Q4S; -.
DR   PDBsum; 3QVB; -.
DR   PDBsum; 3RMV; -.
DR   PDBsum; 3RMW; -.
DR   PDBsum; 3T7M; -.
DR   PDBsum; 3T7N; -.
DR   PDBsum; 3T7O; -.
DR   PDBsum; 3U2T; -.
DR   PDBsum; 3U2U; -.
DR   PDBsum; 3U2V; -.
DR   PDBsum; 3U2W; -.
DR   PDBsum; 3U2X; -.
DR   ProteinModelPortal; P46976; -.
DR   SMR; P46976; -.
DR   BioGrid; 109247; 19.
DR   IntAct; P46976; 14.
DR   MINT; MINT-5000544; -.
DR   STRING; 9606.ENSP00000340736; -.
DR   DrugBank; DB01861; Uridine diphosphate glucose.
DR   DrugBank; DB03435; Uridine-5'-Diphosphate.
DR   CAZy; GT8; Glycosyltransferase Family 8.
DR   iPTMnet; P46976; -.
DR   PhosphoSitePlus; P46976; -.
DR   BioMuta; GYG1; -.
DR   EPD; P46976; -.
DR   MaxQB; P46976; -.
DR   PaxDb; P46976; -.
DR   PeptideAtlas; P46976; -.
DR   PRIDE; P46976; -.
DR   DNASU; 2992; -.
DR   Ensembl; ENST00000296048; ENSP00000296048; ENSG00000163754. [P46976-2]
DR   Ensembl; ENST00000345003; ENSP00000340736; ENSG00000163754. [P46976-1]
DR   Ensembl; ENST00000484197; ENSP00000420683; ENSG00000163754. [P46976-3]
DR   GeneID; 2992; -.
DR   KEGG; hsa:2992; -.
DR   UCSC; uc003ewn.4; human. [P46976-1]
DR   CTD; 2992; -.
DR   DisGeNET; 2992; -.
DR   GeneCards; GYG1; -.
DR   HGNC; HGNC:4699; GYG1.
DR   HPA; HPA030497; -.
DR   MalaCards; GYG1; -.
DR   MIM; 603942; gene.
DR   MIM; 613507; phenotype.
DR   MIM; 616199; phenotype.
DR   neXtProt; NX_P46976; -.
DR   OpenTargets; ENSG00000163754; -.
DR   Orphanet; 263297; Glycogen storage disease due to glycogenin deficiency.
DR   PharmGKB; PA29077; -.
DR   eggNOG; KOG1950; Eukaryota.
DR   eggNOG; COG5597; LUCA.
DR   GeneTree; ENSGT00390000004721; -.
DR   HOGENOM; HOG000008282; -.
DR   HOVERGEN; HBG000681; -.
DR   InParanoid; P46976; -.
DR   KO; K00750; -.
DR   OMA; SESHDPN; -.
DR   OrthoDB; EOG091G09E1; -.
DR   PhylomeDB; P46976; -.
DR   TreeFam; TF312839; -.
DR   BioCyc; MetaCyc:HS08931-MONOMER; -.
DR   BRENDA; 2.4.1.186; 2681.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   Reactome; R-HSA-3814836; Glycogen storage disease type XV (GYG1).
DR   Reactome; R-HSA-3828062; Glycogen storage disease type 0 (muscle GYS1).
DR   Reactome; R-HSA-3878781; Glycogen storage disease type IV (GBE1).
DR   Reactome; R-HSA-5357572; Lysosomal glycogen catabolism.
DR   Reactome; R-HSA-5357609; Glycogen storage disease type II (GAA).
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   UniPathway; UPA00164; -.
DR   ChiTaRS; GYG1; human.
DR   EvolutionaryTrace; P46976; -.
DR   GenomeRNAi; 2992; -.
DR   PRO; PR:P46976; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163754; -.
DR   CleanEx; HS_GYG1; -.
DR   ExpressionAtlas; P46976; baseline and differential.
DR   Genevisible; P46976; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0008466; F:glycogenin glucosyltransferase activity; EXP:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005978; P:glycogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0005980; P:glycogen catabolic process; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR002495; Glyco_trans_8.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF01501; Glyco_transf_8; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Disease mutation; Glycogen biosynthesis; Glycogen storage disease;
KW   Glycoprotein; Manganese; Metal-binding; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   CHAIN         2    350       Glycogenin-1. {ECO:0000305}.
FT                                /FTId=PRO_0000215176.
FT   REGION      301    333       Interaction with GYS1.
FT                                {ECO:0000269|PubMed:17055998}.
FT   ACT_SITE     86     86       {ECO:0000250|UniProtKB:P13280}.
FT   METAL       102    102       Manganese.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   METAL       104    104       Manganese.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   METAL       212    212       Manganese.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   SITE        160    160       Important for catalytic activity.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   SITE        163    163       Important for catalytic activity.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   MOD_RES       2      2       N-acetylthreonine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   CARBOHYD    195    195       O-linked (Glc...) tyrosine.
FT                                {ECO:0000250|UniProtKB:P13280}.
FT   VAR_SEQ     204    350       FGASAKVVHFLGRVKPWNYTYDPKTKSVKSEAHDPNMTHPE
FT                                FLILWWNIFTTNVLPLLQQFGLVKDTCSYVNVLSDLVYTLA
FT                                FSCGFCRKEDVSGAISHLSLGEIPAMAQPFVSSEERKERWE
FT                                QGQADYMGADSFDNIKRKLDTYLQ -> KMSQEPYHICPLG
FT                                RSQLWHSRLYPRKNGRNDGNRARLIIWEQIPLTTSRGNLTL
FT                                TSSRNTAFFCEHIHFTSLVSDT (in isoform GN-
FT                                1S). {ECO:0000305}.
FT                                /FTId=VSP_001768.
FT   VAR_SEQ     277    293       Missing (in isoform GN-1).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:8602861,
FT                                ECO:0000303|PubMed:8661012,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_001769.
FT   VARIANT      16     16       A -> P (in PGBM2).
FT                                {ECO:0000269|PubMed:25272951}.
FT                                /FTId=VAR_072706.
FT   VARIANT      83     83       T -> M (in GSD15; inactivation of the
FT                                autoglucosylation; dbSNP:rs267606858).
FT                                {ECO:0000269|PubMed:20357282}.
FT                                /FTId=VAR_063768.
FT   VARIANT     102    102       D -> H (in PGBM2; dbSNP:rs143137713).
FT                                {ECO:0000269|PubMed:25272951}.
FT                                /FTId=VAR_072707.
FT   STRAND        4     12       {ECO:0000244|PDB:3U2U}.
FT   HELIX        13     28       {ECO:0000244|PDB:3U2U}.
FT   STRAND       33     39       {ECO:0000244|PDB:3U2U}.
FT   HELIX        45     54       {ECO:0000244|PDB:3U2U}.
FT   STRAND       55     60       {ECO:0000244|PDB:3U2U}.
FT   HELIX        69     74       {ECO:0000244|PDB:3U2U}.
FT   HELIX        80     91       {ECO:0000244|PDB:3U2U}.
FT   STRAND       96    101       {ECO:0000244|PDB:3U2U}.
FT   STRAND      105    107       {ECO:0000244|PDB:3U2U}.
FT   HELIX       112    116       {ECO:0000244|PDB:3U2U}.
FT   STRAND      119    124       {ECO:0000244|PDB:3U2U}.
FT   STRAND      126    128       {ECO:0000244|PDB:3U2W}.
FT   STRAND      131    139       {ECO:0000244|PDB:3U2U}.
FT   HELIX       143    156       {ECO:0000244|PDB:3U2U}.
FT   STRAND      159    161       {ECO:0000244|PDB:3RMV}.
FT   HELIX       163    170       {ECO:0000244|PDB:3U2U}.
FT   TURN        171    176       {ECO:0000244|PDB:3U2U}.
FT   HELIX       179    181       {ECO:0000244|PDB:3U2U}.
FT   HELIX       185    187       {ECO:0000244|PDB:3U2U}.
FT   STRAND      188    190       {ECO:0000244|PDB:3U2U}.
FT   HELIX       191    195       {ECO:0000244|PDB:3U2U}.
FT   HELIX       198    204       {ECO:0000244|PDB:3U2U}.
FT   HELIX       205    207       {ECO:0000244|PDB:3U2U}.
FT   STRAND      209    212       {ECO:0000244|PDB:3U2U}.
FT   STRAND      215    217       {ECO:0000244|PDB:3U2U}.
FT   HELIX       219    221       {ECO:0000244|PDB:3U2U}.
FT   STRAND      222    225       {ECO:0000244|PDB:3U2U}.
FT   TURN        226    229       {ECO:0000244|PDB:3U2U}.
FT   STRAND      230    232       {ECO:0000244|PDB:3U2U}.
FT   HELIX       238    240       {ECO:0000244|PDB:3U2U}.
FT   HELIX       244    256       {ECO:0000244|PDB:3U2U}.
FT   HELIX       258    261       {ECO:0000244|PDB:3U2U}.
SQ   SEQUENCE   350 AA;  39384 MW;  ABAEEB7160DEC4DF CRC64;
     MTDQAFVTLT TNDAYAKGAL VLGSSLKQHR TTRRLVVLAT PQVSDSMRKV LETVFDEVIM
     VDVLDSGDSA HLTLMKRPEL GVTLTKLHCW SLTQYSKCVF MDADTLVLAN IDDLFDREEL
     SAAPDPGWPD CFNSGVFVYQ PSVETYNQLL HLASEQGSFD GGDQGILNTF FSSWATTDIR
     KHLPFIYNLS SISIYSYLPA FKVFGASAKV VHFLGRVKPW NYTYDPKTKS VKSEAHDPNM
     THPEFLILWW NIFTTNVLPL LQQFGLVKDT CSYVNVLSDL VYTLAFSCGF CRKEDVSGAI
     SHLSLGEIPA MAQPFVSSEE RKERWEQGQA DYMGADSFDN IKRKLDTYLQ
//
